|
|
Niels C. Riedemann, Ren-Feng Guo, Peter A. Ward
J Clin Invest. 2003;
112(4):460
doi:10.1172/JCI19523
Abstract |
Full text
| PDF
S
epsis remains a serious cause of morbidity and mortality, and the pathophysiology of the disease is not clear. The definition of the clinical manifestations of sepsis is ever evolving. This review discusses the search for effective therapeutic interventions, hurdles in translational sepsis research, and new therapies in development in current clinical trials.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(58)
| Title and authors |
Publication |
Year |
Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death
A. Becerra, C. Echeverria, D. Varela, D. Sarmiento, R. Armisen, F. Nunez-Villena, M. Montecinos, F. Simon
|
Cardiovascular Research
|
2011 |
Transfusion-Transmitted Yersinia enterocolitica Sepsis
F. Guinet, E. Carniel, A. Leclercq
|
Clinical Infectious Diseases
|
2011 |
Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1
Asada Leelahavanichkul, Yuning Huang, Xuzhen Hu, Hua Zhou, Takayuki Tsuji, Richard Chen, Jeffrey B Kopp, Jürgen Schnermann, Peter S T Yuen, Robert A Star
|
Kidney Int
|
2011 |
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth.
Karen A Cavassani, William F Carson, Ana Paula Moreira, Haitao Wen, Matthew A Schaller, Makoto Ishii, Dennis M Lindell, Yali Dou, Nicholas W Lukacs, Venkateshwar G Keshamouni, Cory M Hogaboam, Steven L Kunkel
|
Blood
|
2010 |
High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.
Yoko Oyama, Teruto Hashiguchi, Noboru Taniguchi, Salunya Tancharoen, Tomonori Uchimura, Kamal K Biswas, Ko-Ichi Kawahara, Takao Nitanda, Yoshihisa Umekita, Martin Lotz, Ikuro Maruyama
|
Lab. Invest.
|
2010 |
Insights Into Sepsis Therapeutic Design Based on the Apoptotic Death Pathway
Yuichi Hattori, Ken-ichi Takano, Hiroki Teramae, Seiji Yamamoto, Hiroki Yokoo, Naoyuki Matsuda
|
J Pharmacol Sci
|
2010 |
Sepsis and Endothelial Permeability
Warren L. Lee, Arthur S. Slutsky
|
N Engl J Med
|
2010 |
Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice
T. Murakami, T. Obata, K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, I. Nagaoka
|
International Immunology
|
2009 |
Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis.
Xiaobing Ye, Jianqiang Ding, Xiaozhou Zhou, Guoqian Chen, Shu Fang Liu
|
J. Exp. Med.
|
2008 |
Nihon Shuchu Chiryo Igakukai zasshi
Hiromi Fujii, Junko Kosaka, Susumu Kawanishi, Daisuke Katayama, Satoru Oku, Takeshi Mikane, Tomihiro Fukushima, Hiroaki Tokioka
|
Nihon Shuchu Chiryo Igakukai zasshi
|
2008 |
|
